Year All20252024202320222021202020192018201720162015201420122011 Feb 17, 2017 Ardelyx Reports Clinical Progress and Fourth Quarter and Full Year 2016 Financial Results Feb 15, 2017 Ardelyx Announces Successful Phase 3 Trial of Tenapanor for Hyperphosphatemia in Patients with End-Stage Renal Disease Jan 3, 2017 Ardelyx Announces Initiation of Two Clinical Trials for RDX7675 for Treatment of Hyperkalemia Jan 3, 2017 Ardelyx Announces Presentation at J.P. Morgan 35th Annual Healthcare Conference Nov 7, 2016 Ardelyx Reports Third Quarter 2016 Financial Results and Recent Progress Oct 31, 2016 Ardelyx to Announce Third Quarter 2016 Financial Results on November 7, 2016 Oct 24, 2016 Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer Oct 19, 2016 Ardelyx Announces the Presentation of Positive Global Endpoint Findings from Phase 2b Trial of Tenapanor in Patients with IBS-C at ACG Annual Meeting Sep 22, 2016 Ardelyx to Present at Ladenburg Thalmann 2016 Healthcare Conference Aug 15, 2016 Ardelyx to Present at Wedbush PacGrow Healthcare Conference